Genome Atlas Biospecimen Core Resource

Bridgewater, NJ. July 15, 2008. LabVantage Solutions, Inc. today announced that its SAPPHIRE™

BioBanking Solution has been licensed by the renowned International Genomics Consortium (IGC) based in Phoenix, AZ. IGC was selected by the National Cancer Institute (NCI) and the National Human Genome Research Institute (NHGRI) to lead the Human Cancer Biospecimen Core Resource (BCR) component of the Cancer Genome Atlas (TCGA) pilot project. The SAPPHIRE BioBanking Solution will serve as a key informatics backbone supporting and maintaining the BCR.

In order to enhance its biospecimen collection management solution, IGC considered modifying its current software solution. However, it quickly realized internal development would be too much effort and would require an extended project timeline. As a result, IGC searched for a commercial software package robust and flexible enough to handle the current informatics requirements of the BCR, while also maintaining the capability to manage the growing number of samples handled at IGC. After evaluating a top-tier list of potential vendors, LabVantage’s SAPPHIRE BioBanking Solution was selected based upon product maturity, functionality, architecture, scalability and flexibility. Additionally, LabVantage’s extensive experience delivering solutions for biospecimen repository management was a key decision factor for the IGC.

“In order for the IGC to successfully implement the Human Cancer Biospecimen Core Resource we needed a biospecimen management solution that was functionally rich and capable of being implemented rapidly,” stated Troy Shelton, IGC Project Administrator for TCGA. “Among the software solutions we evaluated, LabVantage’s SAPPHIRE BioBanking Solution offered true out-of–the-box functionality and was by far the most well-established and premier solution used by peers in the industry.” The SAPPHIRE BioBanking Solution ensures that standard procedures are used for all steps in the biorepository management process. Key processes supported include: informed consent, clinical data collection, sample collection, pathology review, biomolecule extractions, quality control, laboratory data collection, and biomolecule distribution.

“ICG’s selection of the SAPPHIRE BioBanking Solution to support its translational genomics and cancer

research is further validation of our industry leading solution for biorepository management,” affirms Ron Kasner, Vice President of Corporate Development for LabVantage. “We are the partner of choice for acclaimed translational research institutes, such as the ICG.”

About IGC. The International Genomics Consortium (IGC) is a non-profit medical research foundation established to expand upon the discoveries of the Human Genome Project and other systematic sequencing efforts by combining world-class genomic research, bioinformatics, and diagnostic technologies in the fight against cancer and other complex genetic diseases. IGC serves numerous common, unmet needs including: the standardization of the collection of properly consented tissues of interest, the molecular characterization of these tissues, and standardization in the representation of

these results. IGC facilitates the transition of genomic discoveries to improve patient care and increase

the speed in which new diagnostic, prognostic and predictive testing, and new drug and treatment

regimens are developed. Founding support for IGC was provided by the City of Phoenix and from

Maricopa County. Further information about IGC is available at www.intgen.org.

About LabVantage. LabVantage Solutions, Inc., an innovative global provider of enterprise solutions

tailored for leading laboratories, serves discovery, development, formulation, process research, raw

material testing, and quality management laboratories across multiple industries. LabVantage’s SAPPHIRE, a zero-footprint laboratory information management suite, is tailored to manage an

organization’s critical laboratory information across its worldwide operations to optimize productivity and more effectively share knowledge. LabVantage is headquartered in Bridgewater, NJ, U.S.A. Further information about LabVantage and SAPPHIRE is available at www.labvantage.com.

LabVantage, SAPPHIREand their respective logos are trademarks or registered trademarks of LabVantage

Solutions, Inc. in the U.S and other countries around the world. All other product and service names mentioned are the trademarks of their respective companies.